119-1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Last action was on 2-21-2025

Bill is currently in: Senate
Path to Law
House

Senate

President

Current status is Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

View Official Bill Information at congress.gov

No users have voted for/against support on this bill yet. Be the first!